Key result
Transapical beating-heart septal myectomy simplifies obstructive HCM treatment by eliminating bypass, sternotomy, and aortotomy.
Why the study?
Conventional septal myectomy is the gold standard for obstructive HCM, but its procedural complexity and required expertise limit its availability beyond high-volume centers.
Does transapical beating-heart septal myectomy (TA-BSM) simplify surgical management and improve recovery compared to conventional septal myectomy in patients with obstructive hypertrophic cardiomyopathy?
Does transapical beating-heart septal myectomy (TA-BSM) simplify surgical management and improve recovery compared to conventional septal myectomy in patients with obstructive hypertrophic cardiomyopathy?
Transapical beating-heart septal myectomy (TA-BSM) with real-time echocardiographic guidance offers a less invasive, cardiopulmonary bypass-free alternative to conventional septal myectomy for obstructive HCM.
Answers are grounded in this paper and cite their sources.
TA-BSM may reduce surgical trauma in obstructive HCM; hypothesis-generating and requires randomized trials before practice change.
Hypertrophic cardiomyopathy (HCM) is a prevalent heterogenous genetic cardiac disorder. In the cardiac myosin inhibitor era, the guideline-directed management of HCM remains an emerging frontier worldwide. Septal myectomy has been the gold standard treatment option for obstructive HCM over the past 60 years. However, the complexity of this procedure and required expertise (and lack of qualified training) have limited its success and availability beyond high-volume HCM centers. Transapical beating-heart septal myectomy (TA-BSM), a newly developed innovative technique, simplifies conventional septal myectomy by eliminating the need for sternotomy, cardiopulmonary bypass, and aortotomy. Most important, the inclusion of real-time intraoperative echocardiographic guidance and evaluation makes TA-BSM safer, more precise, cost-effective, and reproducible. The apparent advantages of TA-BSM, including substantial reductions in surgical trauma and operating times and much faster postoperative recovery in patients with obstructive HCM, are encouraging. TA-BSM is particularly feasible in patients with long-segment obstruction, or small aortic valve annulus, or in those who had undergone previous cardiac operations. The frequent resolution of systolic anterior motion and associated mitral regurgitation after TA-BSM, without concomitant mitral valve intervention, highlights the central role of intraoperative echocardiography and close surgeon-echocardiographer collaboration in achieving optimal procedural outcomes. Further multicenter evaluation of TA-BSM will help define its role among septal reduction strategies for patients with obstructive HCM.
No takes yet. Share an insight, caveat, or question.
Wei et al. (2026) conducted a review in Obstructive hypertrophic cardiomyopathy (HCM). Transapical beating-heart septal myectomy (TA-BSM) with real-time intraoperative echocardiographic guidance vs. Conventional septal myectomy was evaluated. Transapical beating-heart septal myectomy (TA-BSM) simplifies conventional myectomy for obstructive HCM by eliminating sternotomy, cardiopulmonary bypass, and aortotomy.
Synapse has enriched 10 related papers. Consider them for comparative context: